Email updates

Keep up to date with the latest news and articles from Arthritis Research & Therapy and BioMed Central.

Open Access Research article

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

Marie Hudson*, Janet Pope, Michael Mahler, Solène Tatibouet, Russell Steele, Murray Baron, Canadian Scleroderma Research Group (CSRG) and Marvin J Fritzler

Arthritis Research & Therapy 2012, 14:R50 doi:10.1186/ar3763

Accesses  

  • Last 30 days: 242 accesses
  • Last 365 days: 2772 accesses
  • All time: 3775 accesses

Cited by